Fibrinogen Antikörper und Ähnliche Produkte
Santa Cruz Biotechnology bietet eine große Auswahl an Fibrinogen-Antikörpern für verschiedene Forschungsanwendungen. Die monoklonalen Fibrinogen-Antikörper sind kompatibel mit Western Blotting (WB), Immunpräzipitation (IP), Immunfluoreszenz (IF), Immunhistochemie mit Paraffin eingebetteten Schnitten (IHCP), Durchflusszytometrie (FCM) und Enzymimmunoassay (ELISA). Fibrinogen ist ein wichtiges Plasmaprotein, das an der Gerinnungskaskade beteiligt ist und eine entscheidende Rolle bei der Bildung von Blutgerinnseln und der Wundheilung spielt. Fibrinogen ist im Zusammenhang mit Herz-Kreislauf-Erkrankungen und Entzündungsreaktionen eingehend untersucht worden. Das Verständnis der Funktion und Regulierung von Fibrinogen treibt die Forschung auf dem Gebiet der Hämostase und Thrombose weiter voran. Forscher auf der ganzen Welt nutzen Fibrinogen-Antikörper, um zelluläre Abläufe und molekulare Mechanismen zu untersuchen. Fortgeschrittene Forschungstechniken, bei denen Fibrinogen-Antikörper zum Einsatz kommen, haben neue Erkenntnisse über Blutgerinnungsstörungen und potenzielle therapeutische Ziele erbracht. Monoklonale Fibrinogen-Antikörper von Santa Cruz Biotechnology ermöglichen es Forschern, einen bedeutenden Beitrag zum wissenschaftlichen Verständnis der Blutgerinnung und verwandter Erkrankungen zu leisten.
Siehe auch...
Learn more about our ImmunoCruz® Antibody Conjugates and Cruz Marker™ MW Standards Promotional
Fibrinogen Antikörper
| Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|---|
Fibrinogen Antikörper (6G12) | sc-51898 | mouse IgG1 | (h) | WB, IP | h | neu | ||
Fibrinogen Antikörper (27C8) | sc-51894 | mouse IgG2a | (h) | WB, IP | h | neu | ||
Fibrinogen Antikörper (40F11) | sc-51895 | mouse IgG1 | (h) | WB, IP | h | neu | ||
Fibrinogen Antikörper (GMA-035) | sc-65966 | mouse IgG1 | FL (h) | WB | h | 3 | ||
Fibrinogen α Antikörper (C-7) | sc-398806 | mouse IgG2b κ | 581-607 (h) | WB, IP, IF, ELISA | m, r, h | 10 | ||
Fibrinogen α Antikörper (A-6) | sc-166968 | mouse IgG2a κ | 21-320 (h) | WB, IP, IF, ELISA | h | 4 | ||
Fibrinogen α Antikörper (1F7) | sc-51892 | mouse IgG2a | (h) | WB, IP | m, r, h | 1 | ||
Fibrinogen α Antikörper (471CT12.1.2) | sc-517331 | mouse IgM | 420-448 (h) | WB, IP | m, r, h | neu | ||
Fibrinogen α Antikörper (UC45) | sc-53284 | mouse IgM κ | (h) | IF | h | neu | ||
Fibrinogen β Antikörper (D-4) | sc-271035 | mouse IgG2a κ | 31-300 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 4 | ||
Fibrinogen β Antikörper (C-1) | sc-271017 | mouse IgG2b κ | 31-300 (h) | WB, IP, IF, ELISA | m, r, h | 2 | ||
Fibrinogen β Antikörper (E-5) | sc-271018 | mouse IgG1 κ | 31-300 (h) | WB, IP, IF, ELISA | h | neu | ||
Fibrinogen γ Antikörper (D-6) | sc-133226 | mouse IgG1 κ | 27-220 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 2 | ||
Fibrinogen γ Antikörper (B-1) | sc-133157 | mouse IgG1 κ | 27-220 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 5 | ||
Fibrinogen γ Antikörper (2.G2.H9) | sc-81620 | mouse IgG1 κ | 434-453 (h) | WB, IP, IHC(P) | h | 6 | ||
Fibrinogen γ Antikörper (G-10) | sc-133156 | mouse IgG1 κ | 27-220 (h) | WB, IP, IF, ELISA | m, r, h | 1 |
Fibrinogen CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
Fibrinogen α CRISPR/Cas9 KO Plasmid (h) | sc-400793 | h | Gene Knockout | GFP | 0 | ||
Fibrinogen α CRISPR/Cas9 KO Plasmid (h2) | sc-400793-KO-2 | h | Gene Knockout | GFP | 0 | ||
Fibrinogen α HDR Plasmid (h2) | sc-400793-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
Fibrinogen α Double Nickase Plasmid (h) | sc-400793-NIC | h | Gene Knockout | Puromycin | 0 | ||
Fibrinogen α Double Nickase Plasmid (h2) | sc-400793-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Fibrinogen α CRISPR/Cas9 KO Plasmid (m) | sc-420321 | m | Gene Knockout | GFP | 0 | ||
Fibrinogen α HDR Plasmid (m) | sc-420321-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Fibrinogen α Double Nickase Plasmid (m) | sc-420321-NIC | m | Gene Knockout | Puromycin | 0 | ||
Fibrinogen α Double Nickase Plasmid (m2) | sc-420321-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Fibrinogen β CRISPR/Cas9 KO Plasmid (h) | sc-401819 | h | Gene Knockout | GFP | 0 | ||
Fibrinogen β HDR Plasmid (h) | sc-401819-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Fibrinogen β Double Nickase Plasmid (h) | sc-401819-NIC | h | Gene Knockout | Puromycin | 0 | ||
Fibrinogen β Double Nickase Plasmid (h2) | sc-401819-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Fibrinogen β CRISPR/Cas9 KO Plasmid (m) | sc-430993 | m | Gene Knockout | GFP | 0 | ||
Fibrinogen β HDR Plasmid (m) | sc-430993-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Fibrinogen β Double Nickase Plasmid (m) | sc-430993-NIC | m | Gene Knockout | Puromycin | 0 | ||
Fibrinogen β Double Nickase Plasmid (m2) | sc-430993-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Fibrinogen γ CRISPR/Cas9 KO Plasmid (h) | sc-416704 | h | Gene Knockout | GFP | 0 | ||
Fibrinogen γ HDR Plasmid (h) | sc-416704-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Fibrinogen γ Double Nickase Plasmid (h) | sc-416704-NIC | h | Gene Knockout | Puromycin | 0 | ||
Fibrinogen γ Double Nickase Plasmid (h2) | sc-416704-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Fibrinogen γ CRISPR/Cas9 KO Plasmid (m) | sc-430271 | m | Gene Knockout | GFP | 0 | ||
Fibrinogen γ HDR Plasmid (m) | sc-430271-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Fibrinogen γ Double Nickase Plasmid (m) | sc-430271-NIC | m | Gene Knockout | Puromycin | 0 | ||
Fibrinogen γ Double Nickase Plasmid (m2) | sc-430271-NIC-2 | m | Gene Knockout | Puromycin | 0 |
Fibrinogen CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
Fibrinogen α CRISPR Activation Plasmid (h) | sc-400793-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen α CRISPR Activation Plasmid (h2) | sc-400793-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen α Lentiviral Activation Particles (h) | sc-400793-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen α Lentiviral Activation Particles (h2) | sc-400793-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen α CRISPR Activation Plasmid (m) | sc-420321-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen α CRISPR Activation Plasmid (m2) | sc-420321-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen α Lentiviral Activation Particles (m) | sc-420321-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen α Lentiviral Activation Particles (m2) | sc-420321-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen β CRISPR Activation Plasmid (h) | sc-401819-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen β CRISPR Activation Plasmid (h2) | sc-401819-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen β Lentiviral Activation Particles (h) | sc-401819-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen β Lentiviral Activation Particles (h2) | sc-401819-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen β CRISPR Activation Plasmid (m) | sc-430993-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen β CRISPR Activation Plasmid (m2) | sc-430993-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen β Lentiviral Activation Particles (m) | sc-430993-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen β Lentiviral Activation Particles (m2) | sc-430993-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen γ CRISPR Activation Plasmid (h) | sc-416704-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen γ CRISPR Activation Plasmid (h2) | sc-416704-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen γ Lentiviral Activation Particles (h) | sc-416704-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen γ Lentiviral Activation Particles (h2) | sc-416704-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen γ CRISPR Activation Plasmid (m) | sc-430271-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen γ CRISPR Activation Plasmid (m2) | sc-430271-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen γ Lentiviral Activation Particles (m) | sc-430271-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Fibrinogen γ Lentiviral Activation Particles (m2) | sc-430271-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
Fibrinogen siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
Fibrinogen α siRNA (h) | sc-40409 | h | Gene Silencing | N/A | 0 | ||
Fibrinogen α shRNA Plasmid (h) | sc-40409-SH | h | Gene Silencing | Puromycin | 0 | ||
Fibrinogen α shRNA (h) Lentivirale Partikel | sc-40409-V | h | Gene Silencing | Puromycin | 0 | ||
Fibrinogen α siRNA (m) | sc-40410 | m | Gene Silencing | N/A | 0 | ||
Fibrinogen α shRNA Plasmid (m) | sc-40410-SH | m | Gene Silencing | Puromycin | 0 | ||
Fibrinogen α shRNA (m) Lentivirale Partikel | sc-40410-V | m | Gene Silencing | Puromycin | 0 | ||
Fibrinogen β siRNA (h) | sc-37096 | h | Gene Silencing | N/A | 1 | ||
Fibrinogen β shRNA Plasmid (h) | sc-37096-SH | h | Gene Silencing | Puromycin | 1 | ||
Fibrinogen β shRNA (h) Lentivirale Partikel | sc-37096-V | h | Gene Silencing | Puromycin | 1 | ||
Fibrinogen β siRNA (m) | sc-37097 | m | Gene Silencing | N/A | 0 | ||
Fibrinogen β shRNA Plasmid (m) | sc-37097-SH | m | Gene Silencing | Puromycin | 0 | ||
Fibrinogen β shRNA (m) Lentivirale Partikel | sc-37097-V | m | Gene Silencing | Puromycin | 0 | ||
Fibrinogen γ siRNA (h) | sc-37098 | h | Gene Silencing | N/A | 0 | ||
Fibrinogen γ shRNA Plasmid (h) | sc-37098-SH | h | Gene Silencing | Puromycin | 0 | ||
Fibrinogen γ shRNA (h) Lentivirale Partikel | sc-37098-V | h | Gene Silencing | Puromycin | 0 | ||
Fibrinogen γ siRNA (m) | sc-37099 | m | Gene Silencing | N/A | 0 | ||
Fibrinogen γ shRNA Plasmid (m) | sc-37099-SH | m | Gene Silencing | Puromycin | 0 | ||
Fibrinogen γ shRNA (m) Lentivirale Partikel | sc-37099-V | m | Gene Silencing | Puromycin | 0 |